MYANNE HINOTE: Open Payments
NPI 1215612080 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 40 payments from 14 companies in 2025. Trend: 2023 $339 · 2024 $823 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $183 |
| PFIZER INC. | 9 | $146 |
| Astellas Pharma US Inc | 2 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Amgen Inc. | 3 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Radius Health, Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: QULIPTA, ELIQUIS, NURTEC ODT, Veozah, MOUNJARO, VRAYLAR, EVENITY, SPRAVATO.
Industry payments across FL — which companies pay providers there.
